Category: NuvasiveSyndicate content

NuVasive loses 2nd, $30M trademark trial against NeuroVision

April 4, 2014 by Brad Perriello

NuVasive pledges to appeal a $30 million loss in a trademark infringement lawsuit leveled against it by NeuroVision Medical Products, the 2nd time a court found against NuVasive.

NuVasive loses 2nd, $30M trademark trial against NeuroVision

UPDATED April 7, 2014, with comment from NeuroVision

NuVasive shares jump on Street-beating Q4 numbers

March 4, 2014 by Brad Perriello

Shares of NuVasive jump on Wall Street today after the medical device company reports earnings ahead of analysts' expectations.

NuVasive shares jump on Street-beating Q4 numbers

NuVasive Inc. (NSDQ:NUVA) shares gained nearly 8% today after the medical device company reported beating expectations with its 4th-quarter earnings as it swung to black ink.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive adds to executive committee

February 7, 2014 by Chris Walker

NuVasive brings in some new blood to its executive committee, naming a new human resources head and promoting its investor relations vice president.

NuVasive shuffles its management

NuVasive Inc. (NSDQ:NUVA) said it hired a pair of new vice presidents to lead for its human resource and finance departments, promoting from within for 1 spot and looking outside for the other.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive must face AngleFix patent infringement lawsuit

January 22, 2014 by Brad Perriello

NuVasive loses a bid to toss a patent infringement lawsuit filed by AngleFix over plate-and-screw spinal implant technology.

NuVasive must face AngleFix patent infringement lawsuit
NuVasive must face AngleFix patent infringement lawsuit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive soars on estimates for Q4 and 2014

January 15, 2014 by Arezu Sarvestani

Minimally invasive surgical devices maker NuVasive gets some Wall Street love after announcing strong preliminary results for its 4th quarter.

NuVasive soars on new outlook, preliminary earnings

California medical device maker NuVasive Inc. (NSDQ:NUVA) is flying high today after raising its revenue projections for 2013 amid higher-than-expected 4th quarter sales.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp